Follow
Robert L. Medcalf
Robert L. Medcalf
Verified email at monash.edu
Title
Cited by
Cited by
Year
Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity
AL Samson, RL Medcalf
Neuron 50 (5), 673-678, 2006
2262006
Vampire bat salivary plasminogen activator (desmoteplase) a unique fibrinolytic enzyme that does not promote neurodegeneration
GT Liberatore, A Samson, C Bladin, WD Schleuning, RL Medcalf
Stroke 34 (2), 537-543, 2003
2202003
Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter.
M Zimmer, RL Medcalf, TM Fink, C Mattmann, P Lichter, DE Jenne
Proceedings of the National Academy of Sciences 89 (17), 8215-8219, 1992
2121992
Glucocorticoid-modulated gene expression of tissue-and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
RL Medcalf, E Van den Berg, WD Schleuning
The Journal of cell biology 106 (3), 971-978, 1988
1891988
Fibrinolysis, inflammation, and regulation of the plasminogen activating system
RL Medcalf
Journal of Thrombosis and Haemostasis 5, 132-142, 2007
1752007
The undecided serpin: the ins and outs of plasminogen activator inhibitor type 2
RL Medcalf, SJ Stasinopoulos
The FEBS journal 272 (19), 4858-4867, 2005
1682005
Reduced phosphoinositide 3-kinase (p110α) activation increases the susceptibility to atrial fibrillation
L Pretorius, XJ Du, EA Woodcock, H Kiriazis, RCY Lin, S Marasco, ...
The American journal of pathology 175 (3), 998-1009, 2009
1642009
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
JF Cajot, J Bamat, GE Bergonzelli, EK Kruithof, RL Medcalf, J Testuz, ...
Proceedings of the National Academy of Sciences 87 (18), 6939-6943, 1990
1611990
Haemostasis and innate immunity–a complementary relationship: a review of the intricate relationship between coagulation and complement pathways
CB Keragala, DF Draxler, ZK McQuilten, RL Medcalf
British journal of haematology 180 (6), 782-798, 2018
1572018
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.
RL Medcalf, EK Kruithof, WD Schleuning
The Journal of experimental medicine 168 (2), 751-759, 1988
1571988
Inhibition of interleukin 1β-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP
CJ Hawkins, AG Uren, G Häcker, RL Medcalf, DL Vaux
Proceedings of the National Academy of Sciences 93 (24), 13786-13790, 1996
1561996
A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate …
RL Medcalf, M Rüegg, WD Schleuning
Journal of Biological Chemistry 265 (24), 14618-14626, 1990
1561990
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury
SR Shultz, DK Wright, P Zheng, R Stuchbery, SJ Liu, M Sashindranath, ...
Brain 138 (5), 1297-1313, 2015
1542015
Tissue‐type plasminogen activator requires a co‐receptor to enhance NMDA receptor function
AL Samson, ST Nevin, D Croucher, B Niego, PB Daniel, TW Weiss, ...
Journal of neurochemistry 107 (4), 1091-1101, 2008
1432008
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells
WD Schleuning, RL Medcalf, C Hession, R Rothenbühler, A Shaw, ...
Molecular and cellular biology 7 (12), 4564-4567, 1987
1401987
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
JF Cajot, WD Schleuning, RL Medcalf, J Bamat, J Testuz, L Liebermann, ...
The Journal of cell biology 109 (2), 915-925, 1989
1361989
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
R Picetti, H Shakur-Still, RL Medcalf, JF Standing, I Roberts
Blood coagulation & fibrinolysis 30 (1), 1-10, 2019
1332019
Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury
C Reddrop, RX Moldrich, PM Beart, M Farso, GT Liberatore, DW Howells, ...
Stroke 36 (6), 1241-1246, 2005
1272005
Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction
Y Liu, XM Gao, L Fang, NL Jennings, Y Su, AL Samson, H Kiriazis, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (4), 834-841, 2011
1242011
Fibrinolysis and COVID‐19: a plasmin paradox
RL Medcalf, CB Keragala, PS Myles
Journal of Thrombosis and Haemostasis 18 (9), 2118-2122, 2020
1232020
The system can't perform the operation now. Try again later.
Articles 1–20